Cardiovascular Week articles from February 2004

Cardiovascular Week archives from February 2004

Plasma AM linked to PWV in older patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Plasma AM levels are strongly linked to PWV in middle-aged and older individuals. "Arterial stiffness as measured by pulse wave velocity (PWV) is a major predictor of cardiovascular disease,"...

Myocardial infarction reported after influenza vaccination.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Researchers review adverse effects occurring after influenza vaccination in a recent issue of Zeitschrift Fur Kardiologie. According to research from Germany, "Influenza is a common disease in the...

Insulin-like growth factor-1 protects myocardial tissue against ischemia.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Insulin-like growth factor-1 protects myocardial tissue against ischemia. According to recent research from the United States, "Insulin-like growth factor (IGF)-1 is a well characterized growth...

Palivizumab used for prophylaxis against respiratory syncytial virus.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Palivizumab is recommended for use as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease. "New data are emerging on the use of palivizumab as prophylaxis...

Study reviews issues of DVT associated with central venous catheters.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Additional studies may be needed to provide sound recommendations for upper-limb deep venous thrombosis (UL-DVT) prophylaxis in cancer patients with long-term central venous catheters (CVCs). ...

Company submits Powerlink PMA to the FDA.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Endologix, Inc., (ELGX) announced that it has filed its completed premarket approval (PMA) submission with the U.S. Food and Drug Administration (FDA) for the PowerLink System, an endoluminal stent...

Hard water (and fluoride) may protect against heart attacks.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Hard water may protect against coronary artery disease and heart attacks, suggests Finnish research. Fluoride also seems to exert a protective effect, finds the research. Prompted by the seemingly...

Inorganic arsenic therapies may have toxic side effects.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Inorganic arsenic therapies may have toxic side effects. According to published research from the United States, "trivalent inorganic arsenic (arsenite, arsenic trioxide, As (III) is currently...

Medication reduces angina attacks, increases exercise capacity for patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Taken with other anti-anginal medications, the drug ranolazine reduces the frequency of angina and increases exercise capacity in patients with severe chronic angina, according to a new study. ...

Estrogen protects cells from certain death after an ischemic stroke.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Estrogen protects cells from certain death after an ischemic stroke. "Estradiol is a known neurotrophic and neuroprotective factor. Our previous work demonstrated that replacement with physiological...

Glycated compounds spawn angiogenic induction in cultured endothelial cells.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Glycated compounds spawn angiogenic induction in cultured endothelial cells. According to a study from Japan, "glycation has been implicated in the endothelial dysfunction that contributes to both...

Tryptophanyl-tRNA synthetase fragments control response to shear stress.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Tryptophanyl-tRNA synthetase fragments control response to shear stress. According to recent research from the United States, "human tryptophanyl-tRNA synthetase (TrpRS) is active in translation and...

Apolipoprotein-E-deficient mice resistant to atherosclerosis.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. "The aims of this study were to determine whether mice induced to...

Benefits of niacin treatment reviewed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The oft-overlooked cardiovascular benefits of niacin have been reviewed. "Cardiovascular event reduction in hypercholesterolemic subjects appropriately emphasizes the prominent role of statin...

Live 3-D echocardiography shows promise for fetal heart exams.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Live 3-D echocardiography shows great promise for fetal diagnosis of congenital heart defects. Cardiologists in New York conducted a study "to investigate the feasibility of using a new...

Antioxidants reduce VEGF and VEGFR expression in atherosclerosis models.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Antioxidants reduce VEGF and VEGFR expression in atherosclerosis models. "Antiangiogenic therapy reduces both plaque growth and intimal neovascularization in apolipoprotein-E-deficient mice...

Cardiac sympathovagal interaction increases during sex.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Cardiac sympathovagal interaction is increased during sexual intercourse. In a recent study, scientists in Michigan "analyzed heart rate variability during sexual activity using complex...

Fully implantable, completely electric artificial heart developed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Researchers have developed a fully implantable, completely electric artificial heart, the 'AbioCor.' "The fully implantable complete electric artificial heart 'AbioCor' is the ultimate stage in the...

Aneurysm location may influence endoaneurysmorrhaphy outcome.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Aneurysm location may influence endoaneurysmorrhaphy outcome. "Endoaneurysmorrhaphy is mostly performed on anterior-septal left ventricular (LV) aneurysms. It may also be applied to posterior...

Bax mediates protective effects of Rho-kinase blockade after vascular injury.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The pro-apoptotic Bax protein mediates the protective effects of Rho-kinase blockade after vascular injury. "Recently," scientists in Japan found that "a specific Rho-kinase inhibitor, Y27632...

Homocysteinylated transthyretin may contribute to pathogenesis.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Homocysteinylated transthyretin may play a role in the pathogenesis of amyloid disease. "Hyperhomocysteinemia is an independent risk factor for cardiovascular disease and an emerging risk factor for...

Progression of chronic heart failure reviewed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The progression of chronic heart failure has been reviewed. "Chronic heart failure is a progressive syndrome that starts with impaired left ventricular function and progresses to end-stage heart...

Rise in homocysteine level rapidly increases arterial stiffness.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- A rise in homocysteine levels causes a rapid increase in arterial stiffness. "Homocysteine appears to be causally related to cardiovascular disease and shown to induce endothelial dysfunction,"...

Role of oxidative stress in cardiac hypertrophy confirmed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The putative role of oxygen radicals in the pathogenesis of cardiac hypertrophy has been confirmed. "Oxidative stress is known to contribute to numerous cardiac disease processes," scientists in...

Role of oxidative stress in cardiomyocyte apoptosis reviewed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The putative role of oxidative stress in cardiac cell apoptosis has been reviewed. "Cardiomyocyte (CM) apoptosis has been reported in a variety of cardiovascular diseases, including myocardial...

Type 6 adenylyl cyclase gene mutations may increase LVH risk in Japanese patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Adenylyl cyclase gene mutations may increase the LVH risk in Japanese individuals. In a recent study, cardiologists in the United States "investigated whether polymorphism of the type 6 adenylyl...

Results of CHF drug trials reported.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Results from a variety of CHF drug trials have been reported. "There is now evidence for the efficacy and safety of a variety of neurohormonal modulators in chronic heart failure (CHF),"...

Should indications for CRT be expanded?
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Should clinical indications for cardiac resynchronization therapy (CRT) be expanded? CRT "has been shown to improve symptoms and quality of life of patients suffering from systolic heart failure...

Utility of endothelin-1 receptor blockade for heart failure patients reviewed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The utility of endothelin-1 receptor antagonist therapy for heart failure has been reviewed. "Endothelin-1 is a vasoconstrictor peptide playing an important role in the pathophysiology of heart...

IND filed for phase I/II trial of MagneTarg system to deliver mitomycin C.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- FeRx, Inc., a targeted drug delivery company, announced that the U.S. Food and Drug Administration has allowed the phase I/II clinical trial submitted in an investigational new drug (IND) application...

AED equipment sold to major pharmaceutical firms.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB), a manufacturer of automated public-access defibrillators (AEDs), announced that it has been awarded multiyear contracts by several pharmaceutical manufacturers, including...

Alliance to develop nitric oxide-coated stents extended.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- NitroMed, Inc., (NTMD) announced the extension of an exclusive worldwide research collaboration, licensing, and commercialization agreement with Boston Scientific Corporation (BSX) for the development...

Coating, drug-eluting technology licensed for stent platform.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Devax and Occam International B.V., an affiliate of Biosensors International, jointly announced that they have signed a license agreement to incorporate Occam's proprietary coating and drug Biolimus A9...

GenVec, Cordis Corp. ink BIOBYPASS agreement.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC) has entered into a research collaboration with the Cordis Cardiology Division of Cordis Corp., a Johnson & Johnson company, to study the clinical benefit of BIOBYPASS in a procedure...

Researchers study ways to better treat patients with heart defects.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- In new studies, Mayo Clinic researchers report on procedures that were successful in closing an opening in the heart that fails to completely close after birth in approximately one-fourth of the United...

Beta blockers cost-effective to society for heart failure treatment.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Beta-blocker therapy for the treatment of heart failure can provide significant cost savings for the health care system, according to a new analysis by researchers at the Duke Clinical Research...

Exercise improves survival in heart patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Properly supervised exercise programs improve survival in people with chronic heart failure, finds new research. At present, exercise is not widely used because good evidence is lacking. The study...

FDA 510k clearance granted for dual lumen extended length catheter.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- CHF Solutions has received 510(k) marketing clearance from the U.S. Food and Drug Administration for a dual lumen extended length catheter (dELC) for use with the company's System 100 Fluid Removal...

Blood clot risk not treated preventively, study finds.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- In a nationwide study of hospitalized patients, researchers at Duke University Medical Center and Brigham and Women's Hospital found that people at risk for developing deep vein thrombosis (DVT) - a...

Are U.K. guidelines for reducing salt intake ambitious enough?
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Are the U.K. guidelines for reducing dietary salt intake ambitious enough to have a major impact on cardiovascular disease rates? "The current public health recommendations are to reduce salt...

Dietary recommendations may change in the light of prehistoric diets.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Dietary recommendations may change after considering the content of prehistoric diets. "In view of the results of comprehensive prospective epidemiological studies obtained recently, the preventive...

Fish supplement changes endometrial and plasma n-3 fatty acid levels in cows.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Fish supplement changes endometrial and plasma n-3 fatty acid levels in cows. "Seven nonlactating mature Angus cows (4 to 10 years old) were used to examine the effects of fish meal supplementation...

Low-dose betaine supplementation reduces plasma homocysteine levels.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Low-dose betaine dietary supplements produce immediate and sustained reductions in plasma homocysteine levels. "High plasma homocysteine is a risk for cardiovascular disease and can be lowered...

Reducing Na+ intake during high K+ diet lowers blood pressure.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Reducing dietary Na+ during a high K+ diet significantly reduces blood pressure. According to recent research from Australia, "Reducing dietary sodium reduces blood pressure (BP), a major risk...

Company enters $15M digital electrocardiogram franchise agreement.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) has entered into an agreement with a total value of $15 million over 3 years with a top 15 pharmaceutical organization to provide comprehensive cardiac safety and...

$32M raised to advance multiple cardiovascular device opportunities.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Accelerated Technologies, Inc., (ATI), a New York-based partnership model for the creation and acceleration of cardiovascular devices into the market, announced that it received $32 million in funding...

Multiple promoters control WNK1 gene expression.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Multiple promoters control WNK1 gene expression. "WNK1 is a serine-threonine kinase, the expression of which is affected in pseudohypoaldosteronism type II, a Mendelian form of arterial...

Menopause data for Femarelle accepted for peer-review publication.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Researchers at Rabin Medical Center and Se-cure Pharmaceuticals, Ltd., have received word their 12-month clinical study evaluating the efficacy and safety of dietary supplement Femarelle for menopausal...

Moderate exercise improves HQOL in HIV patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- A moderate exercise regimen can significantly improve the physical well-being of HIV patients. Scientists in Germany conducted a study "to examine the effects of a 16-week exercise intervention on...

Reversible cardiomyopathy reported after perinatal HIV infection.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The first known case of reversible cardiomyopathy after perinatal HIV infection has been reported. Cardiologists in Brazil described their experience treating "a patient with advanced perinatal...

Denver police department initiates defibrillation program.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Health Paradigms announced that it has been retained by the Denver Police Department in its initiative to help save lives by developing a Public Access Defibrillator (PAD) program. Health Paradigms...

Rare case of MDMA-induced myocardial infarction reported.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- A rare case of heart attack triggered by the use of MDMA, better known as ecstacy, has been characterized. "Methylene 3, 4 dioxymethamphetamine (MDMA) has been gaining popularity as a recreational...

Perfluorocarbon-based blood substitute to undergo phase II clinical testing.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Synthetic Blood International Inc. (SYBD) announced that phase II clinical testing of Oxycyte, the company's perfluorocarbon (PFC)-based blood substitute and therapeutic oxygen carrier, is on schedule...

Growing number of Americans have hidden risk.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The percentage of individuals with no reported risk factors for heart disease and stroke is decreasing, according to the U.S. Centers for Disease Control and Prevention (CDC). Heart disease and...

Mitochondrial DNA variant linked to left ventricular hypertrophy in diabetes.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- A mitochondrial DNA variant is associated with left ventricular hypertrophy in diabetes. "Diabetes was reported to be associated with a mitochondrial (mt) DNA mutation at 3,243 and variants at...

Risk assessment improves with coronary artery calcium scoring.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Researchers in California conclude that there is evidence that CT scans for calcium can play a significant role in predicting cardiac deaths and may assist physicians in making treatment decisions for...

Reduced brainstem NOS contributes to enhanced sympathetic drive.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Reduced brainstem NOS [nitric oxide synthase] levels contribute to the heightened sympathetic drive in murine HF models. "Recent studies have suggested that central nervous mechanisms are involved...

Use of nesiritide reviewed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The use of nesiritide for heart failure therapy has been reviewed. "Nesiritide is currently indicated for the management of acute decompensated heart failure defined by the presence of volume...

FDA approves engineering enhancements to Novacor LVAS.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- World Heart Corp. (WHT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's premarket approval supplement submission to incorporate several engineering enhancements to...

Integrin-ligand interactions synergize in arterial injury platelet adhesion.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. According to published research from Germany, "Damage to the integrity of...

Drop in hormone therapy use shows doctors heed research findings.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The dramatic drop in prescriptions for postmenopausal hormone replacement therapy after the risks of long-term estrogen/progestin use were announced suggests that physicians respond more readily to new...

Glycation, inflammation, and RAGE play roles in diabetic complications.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Glycation, inflammation, and Receptor for AGE (RAGE) play roles in the development of the macrovascular complications of diabetes. According to a study from the United States, "The cardiovascular...

Differences in hypertensive and normotensive rat brains reported.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Researchers report the differences between natriuretic peptide receptors in the olfactory bulb and hypothalamus from spontaneously hypertensive and normotensive rat brains. "Natriuretic peptide...

Morning blood pressure surge heightens stroke risk.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The increased risk of stroke and similar events in hypertensive patients during the early hours is linked to circadian blood pressure spikes. "Cardiovascular events occur most frequently in the...

Pulse wave velocity influences pulse pressure in Chinese essential hypertension patients.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Pulse wave velocity (PWV) strongly influences pulse pressure (PP) in Chinese essential hypertension patients. According to recent research from China, PWV "is a significant and independent...

Chromosome 1 region linked to blood pressure in SHR identified.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- A chromosome region linked to blood pressure has been identified in the SHRSP murine model of cardiovascular disease. "Recently, a genome-wide screen has shown a major quantitative trait locus...

ACE genotype does not predict response to ACE inhibitors.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- ACE genotype does not predict the response to antihypertensive therapy with ACE inhibitors. Scientists in China conducted a study "to investigate the relationship between polymorphism of the...

Aliskiren reduces blood pressure through renin inhibition.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- The novel antihypertensive agent aliskiren reduces blood pressure through renin inhibition. "Inhibition of the first and rate-limiting step of the renin-angiotensin system has long been an elusive...

Phase III study of Actimmune published in leading journal.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- InterMune, Inc., (ITMN) announced the publication in the New England Journal of Medicine of previously presented results of the company's initial randomized, double-blind, placebo-controlled, phase III...

Coronary stent market share results reported.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- CathTrak Market Watch, a new product available from Goodroe Healthcare Solutions, LLC, is the first to report the actual utilization of interventional cardiac device available in the market. Market...

Study forecasts widespread use of noninvasive imaging techniques.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Within the next 5 years, ECRI expects the utilization of noninvasive computed tomography (CT) angiography to increase rapidly, according to ECRI's Health Technology Forecast, a newly enhanced strategic...

Safe-Cross total occlusion crossing system receives 510k clearance.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Medical device manufacturer IntraLuminal Therapeutics, Inc., of Carlsbad, California, the first company to combine forward-looking guidance with a radio frequency (RF) energy source, has received 510k...

Medical device contract research business acquired.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Charles River Laboratories International, Inc., (CRL) announced that it has acquired River Valley Farms, a privately held medical device contract research business located near Minneapolis, Minnesota....

Collaboration to conduct genetic research on metabolic syndrome.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Perlegen Sciences, Inc., has entered into a collaboration with Pfizer Inc. (PFE) to conduct genetic research to better understand metabolic syndrome. Perlegen will use its technology to genotype...

European pharmaceutical contracts for cardiac safety monitoring services.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, has received an agreement for approximately $1.0 million in cardiac...

Collaboration aims to identify gene variants associated with heart attack.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Perlegen Sciences, Inc., announced a research collaboration with AstraZeneca (AZN) to discover gene variants that predispose patients to heart attack (myocardial infarction). The goal of the...

Hidden cues that make smokers light up.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Smokers trying to kick the habit for 2004 are probably finding it much harder than they expected. New research by University of Sussex psychologists reveals that smokers subconsciously react to all...

Report gives failing grades to state of Missouri.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- In a national report released by the American Lung Association, the state of Missouri received mostly failing grades for its efforts to fight the harmful effects of tobacco use, demonstrating little...

Scoring balloon patent allowed.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- SS&II announced the allowance of all claims of U.S. patent publication no. 20020151924 broadly covering an angioplasty balloon with ridges mounted on its outer surface for treating occluded coronary and...

Heart patients want more information from their doctors.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Both men and women in a recent study of heart patients said they wanted more information from the health professionals who treated them, but it was the men who said they received more of it. The...

Harris Methodist adopts latest Nellcor pulse oximetry technology.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Nellcor, a part of Tyco Healthcare, announced that Harris Methodist Fort Worth (Texas) Hospital has implemented the Nellcor OxiMax pulse oximetry system and Oxinet III central station and paging system...

Many Latino children well on their way to diabetes, heart disease.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- Recent headlines about the health of the nation's youth have raised alarm, but a new study shows that the pervasiveness of the early stages of heart disease and diabetes among Latino children may be...

NCX 4016 successfully achieves primary efficacy endpoint in phase II study.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- NicOx, SA, (NICOX) announced that NCX 4016 reached its primary efficacy endpoint in a phase IIa study in patients with symptomatic peripheral arterial obstructive disease (PAOD). NCX 4016 is a...

Cardiography technology maker appoints medical director.
February 2, 2004... 2004 FEB 2 - (NewsRx.com & NewsRx.net) -- CardioDynamics (CDIC), developer of impedance cardiography (ICG) technology, has appointed Neil W. Treister, MD, MBA, FACC, to fill the newly created position of medical director. This position...